Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-003369-50Phase 4Completed
Phase 4, single-arm trial of passiflora incarnata in test anxiety, None and anxiety disorder, sponsored by Pascoe. Primary endpoint: Anxiolytic effect measured by quantitative EEG and eye-tracking during examination stress. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-003369-50.